Abstract
Introduction: Chronic venous disease is associated with an increased risk of cardiovascular (CV) events, possibly due to systemic inflammation and increased oxidative stress. Hypothesis: To evaluate the impact of chronic venous insufficiency (CVI) on the risk of subsequent CV and limb events in patients undergoing lower extremity revascularization (LER). Methods: Real-world data from the University of Colorado health system, which serves a diverse population of rural and urban patients, were extracted from TriNetX (Cambridge, MA, USA) for patients undergoing LER from 2015 to 2022. The cohort was divided into those with vs without concomitant CVI and assessed for subsequent limb events (defined as major amputation or re-intervention) and CV events (defined as stroke, myocardial infarction or death). Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated between propensity score (PS)-matched patients with and without CVI. Results: Among 5090 patients with LER, the 1370 (27%) with concurrent CVI were older (67±14 vs. 66±14, p <0.01) and had more comorbidities such as hypertension (72 vs. 58%, p <0.01), diabetes (40 vs. 30%, p <0.01), chronic kidney disease (32 vs. 18%, p <0.01), and obesity (28 vs. 15%, p <0.01). During the 2-years following LER, occurrence of CV (37.2% vs. 31.9%) and limb events (27.0% vs. 18.0%) was higher among patients with CVI (upper panel). After PS matching, limb events remained significantly more frequent (HR 1.53, 95% CI 1.273-1.829) in the group with CVI (lower panel). Conclusion: Among patients undergoing LER, the presence of concurrent CVI identifies a population at significantly increased risk for subsequent limb events.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.